FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Country

Certificates

FDA

Document

No Title 0.23 MB
Registration Date 11 Nov 2014
Share

DOXIL®

Medicine Pharmaceuticals Product Number : 59676-960-01

Antineoplastic Agent

Drug Information

Generic
doxorubicin liposomal
NDC Code
59676-960-01
Drug Class
Anthracycline Topoisomerase Inhibitor
Therapeutic Class
Antineoplastic
Dosage form
Suspension
Route of Administration
Intravenous Injection
Therapeutic Area
1.Kaposi’s sarcoma 2.Metastatic ovarian

Indication

Ovarian Cancer, AIDS-Related Kaposi's Sarcoma, Multiple Myeloma, (killing cancer cells)